Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01347047Recruiting

HIBA-Institutional Registry of Amyloidosis

Role: collaborator

NCT04549701Not ApplicableCompleted

Inferior Vena CAVA and Lung UltraSound-guided Therapy in Acute Heart Failure

Role: lead

NCT06166823Not ApplicableUnknown

Electronic Medical Record Alerts to Optimize Medical Therapy in Heart Failure and Reduced Ejection Fraction

Role: lead

NCT05972746Not ApplicableUnknown

Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure

Role: lead

NCT03766789Not ApplicableUnknown

Use of a Smartphone Application to Increase Adherence to Medical Treatment in Patients With an Acute Coronary Syndrome.

Role: lead

All 5 trials loaded